Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The stock options are exercisable at a price of$23.94 per share, the closing price of Intra-Cellular Therapies common stock onFebruary 18, 2020, the grant date.